The federal contract IDV award is a Federal Supply Schedule (FSS) contract under the Pharmaceuticals and Drugs (FSS-61-IB) schedule, awarded by the Veterans Integrated Service Network 12 (VISN 12) of the U.S. Department of Veterans Affairs (VA). The prime contractor is Amphastar Pharmaceuticals, Inc., a for-profit manufacturer of pharmaceutical goods. The $58,244,500 multiple award contract has a period of performance through January 14, 2027 and aims to procure a broad range of drug,...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract awarded by the Department of Veterans Affairs to Day One Biopharmaceuticals, Inc. The contract has a ceiling value of $225,000.00 and a period of performance through December 6, 2029. The contract is for the provision of Drugs, Pharmaceuticals, & Hematology Related Products under FSS Category 65 I B. As a multiple award FSS contract, it allows the VA and other federal agencies to procure these medical products and...
The federal contract IDV is a Federal Supply Schedule (FSS) contract awarded by the U.S. Department of Veterans Affairs, Veterans Integrated Service Network 12 (VISN 12), a civilian agency. The contract has a ceiling value of $419,690.00 and a period of performance ending on September 1, 2027. The prime contractor is Altathera Pharmaceuticals LLC, a for-profit limited liability company that manufactures goods. The purpose of this FSS contract is to provide the VA VISN 12 with "Drugs,...
The federal contract IDV is a Federal Supply Schedule (FSS) contract awarded by the Department of Veterans Affairs (VA) to Boehringer Ingelheim Pharmaceuticals Inc. The contract is for the procurement of drugs, pharmaceuticals, and hematology-related products, with a ceiling value of $5,020,461,140.00. The period of performance extends from the award date of September 15, 2022, to the ultimate completion date of September 14, 2027. As a multiple award FSS contract, this vehicle allows the VA and...
The federal contract IDV award is a Federal Supply Schedule contract (FSS-61-IB) for Pharmaceuticals and Drugs, awarded by the Department of Veterans Affairs (VA) to Biofrontera Inc. The contract has a period of performance from August 15, 2018 to August 31, 2024, with a ceiling value of $451,170.00. The contract aims to procure a range of pharmaceutical and hematology-related products for the VA's healthcare system. As a Federal Supply Schedule contract, it provides a pre-negotiated catalog...
The federal contract IDV represents a Federal Supply Schedule (FSS) contract awarded by the Department of Veterans Affairs (VA) to Amerisource Health Services, LLC. The contract, valued at up to $750,000.00, is for the procurement of drugs, pharmaceuticals, and hematology-related products (FSC 65 I B) for the Veterans Integrated Service Network 12 region. The contract is a multiple-award FSS with a period of performance running from September 15, 2023 to September 14, 2028. As an FSS contract,...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency of the U.S. federal government. The contract was awarded to Amarin Pharma, Inc., a for-profit organization, with a period of performance from September 1, 2024 to August 31, 2029. The contract has a ceiling value of $1,844,760.00 and covers the procurement of drugs, pharmaceuticals, and hematology-related products under the FSS contract...
The federal contract IDV award is a multiple-award Federal Supply Schedule (FSS) contract with Dermavant Sciences Inc. as the prime contractor. The contract was awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 12 and has a ceiling value of $5,066,433.25 with a period of performance through January 14, 2028. The purpose of this FSS contract is to provide drugs, pharmaceuticals, and hematology-related products to the VA. As an FSS contract, it allows federal...
This federal contract IDV award is for a Federal Supply Schedule (FSS) contract under the Pharmaceuticals and Drugs (FSS-61-IB) schedule, held by Pharmacyclics LLC, an AbbVie company. The contract has a ceiling value of $761,600,000 and a period of performance through August 28, 2025. The contract vehicle is intended to provide the Department of Veterans Affairs and its Veterans Integrated Service Network 12 with a diverse selection of drugs, pharmaceuticals, and hematology-related products....
The federal contract IDV award is a Federal Supply Schedule (FSS) contract under the Pharmaceuticals and Drugs (FSS-61-IB) schedule, awarded by the Department of Veterans Affairs (VA) to Antares Pharma Inc. The contract has a ceiling value of $8,334,100.00 and a period of performance through September 14, 2025. This FSS contract provides the VA with a mechanism to procure a wide range of pharmaceutical and hematology-related products from Antares Pharma. The specific items and pricing are...